This section of the COMPANY NAME InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  COMPANY NAME assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQTLMD
Beta(0.03)
Shares Outstanding76.8M
Average Volume (10 days)531.3K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.30)
Sales (TTM)$0.57
Book Value (MRQ)$1.05
Cash Flow (TTM)--
Cash (MRQ)$5.76

Analyst Views

Current Mean RecommendationBuy
Strong Buy2
 
Buy1
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

John W. Kalix
Director, Chief Executive Officer
1,415,093
Acquire
Feb 16, 2021
Sean Banerjee
Chief Technology Officer
88,670
Acquire
Jan 28, 2021
Robert Jason Hallock
Chief Medical Officer
88,670
Acquire
Jan 28, 2021
Hai V. Tran
President and COO
221,675
Acquire
Jan 28, 2021
Christopher K. Knibb
Chief Financial Officer
121,130
Acquire
Jan 28, 2021

Recent SEC Filings

Prospectus
Feb 22, 2021
Company Events
Feb 22, 2021
Insider Buy/Sell
Feb 18, 2021
Amended >= 5% Acquisition
Feb 16, 2021
>= 5% Acquisition
Feb 16, 2021